Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Intra-Cellular Therapies, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ITCI is no longer listed, so this page shows Q1 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 395
- +11 vs. Q4 2024
- Shares held
- 103.1M
- +6.87M (+7.1%) vs. Q4 2024
- Total value
- $13.6B
- +$5.56B (+69.2%) vs. Q4 2024
- New holders
- 160
- 88 more added
- Sold out
- 149
- 117 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $2.54K |
| Q1 2026 | 1 | $2.54K |
| Q4 2025 | 1 | $2.54K |
| Q3 2025 | 1 | $2.54K |
| Q2 2025 | 4 | $4.15M |
| Q1 2025 | 395 | $13.6B |
| Q4 2024 | 387 | $8.08B |
| Q3 2024 | 356 | $7.12B |
| Q2 2024 | 376 | $6.62B |
| Q1 2024 | 346 | $6.15B |
| Q4 2023 | 335 | $6.42B |
| Q3 2023 | 294 | $4.54B |
| Q2 2023 | 288 | $5.34B |
| Q1 2023 | 274 | $4.55B |
| Q4 2022 | 283 | $4.41B |
| Q3 2022 | 274 | $3.89B |
| Q2 2022 | 266 | $4.65B |
| Q1 2022 | 241 | $4.94B |
| Q4 2021 | 208 | $3.60B |
| Q3 2021 | 181 | $2.56B |
| Q2 2021 | 187 | $2.74B |
| Q1 2021 | 170 | $2.30B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Intra-Cellular Therapies, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 0 | $0 | 0.00% | −840,269−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −743,230−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −615,161−100.0% | Sold out |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0 | $0 | 0.00% | −519,083−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −516,719−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −451,146−100.0% | Sold out |
| Emerald Advisers, LLC | 0 | $0 | 0.00% | −438,066−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −383,591−100.0% | Sold out |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 0 | $0 | 0.00% | −380,423−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −369,617−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −294,414−100.0% | Sold out |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −284,657−100.0% | Sold out |
| General American Investors Co Inc | 0 | $0 | 0.00% | −261,780−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −251,823−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −243,123−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −229,078−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −214,320−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −179,085−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −179,000−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −176,870−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −176,000−100.0% | Sold out |
| General Pension Society PZU Joint Stock Co | 0 | $0 | 0.00% | −163,107−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −163,000−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −147,750−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −146,082−100.0% | Sold out |
| Silvercrest Asset Management Group LLC | 0 | $0 | 0.00% | −118,265−100.0% | Sold out |
| M&G Plc | 0 | $0 | 0.00% | −116,814−100.0% | Sold out |
| Privium Fund Management B.V. | 0 | $0 | 0.00% | −97,154−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −97,000−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −87,569−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| EFG Asset Management (North America) Corp. | 0 | $0 | 0.00% | −74,190−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −73,000−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −72,600−100.0% | Sold out |
| Patient Square Capital LP | 0 | $0 | 0.00% | −71,990−100.0% | Sold out |
| HealthInvest Partners AB | 0 | $0 | 0.00% | −71,138−100.0% | Sold out |
| Granahan Investment Management Inc | 0 | $0 | 0.00% | −69,841−100.0% | Sold out |
| Pier Capital, LLC | 0 | $0 | 0.00% | −65,526−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −65,109−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −64,474−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −63,931−100.0% | Sold out |
| Axiom Investors LLC | 0 | $0 | 0.00% | −60,101−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −52,585−100.0% | Sold out |
| 1492 Capital Management LLC | 0 | $0 | 0.00% | −52,537−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −50,010−100.0% | Sold out |
| Mutual of America Capital Management LLC | 0 | $0 | 0.00% | −44,052−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −40,610−100.0% | Sold out |
| Oppenheimer Asset Management Inc. | 0 | $0 | 0.00% | −40,434−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Point72 Europe (London) LLP | 0 | $0 | 0.00% | −38,961−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −37,513−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −37,500−100.0% | Sold out |
| F/M Investments LLC | 0 | $0 | 0.00% | −36,920−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −35,921−100.0% | Sold out |
| Lombard Odier Asset Management (Europe) Ltd | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −31,781−100.0% | Sold out |
| Quantum Private Wealth, LLC | 0 | $0 | 0.00% | −30,142−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −29,562−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −29,364−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −28,631−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −27,668−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −26,030−100.0% | Sold out |
| Natixis Advisors, L.P. | 0 | $0 | 0.00% | −25,085−100.0% | Sold out |
| 1832 Asset Management L.P. | 0 | $0 | 0.00% | −20,700−100.0% | Sold out |
| KLP Kapitalforvaltning AS | 0 | $0 | 0.00% | −20,500−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −20,268−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −20,153−100.0% | Sold out |
| Oak Ridge Investments LLC | 0 | $0 | 0.00% | −19,831−100.0% | Sold out |
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −19,739−100.0% | Sold out |
| Orion Portfolio Solutions, LLC | 0 | $0 | 0.00% | −19,739−100.0% | Sold out |
| Phocas Financial Corp. | 0 | $0 | 0.00% | −19,058−100.0% | Sold out |
| B. Metzler seel. Sohn & Co. AG | 0 | $0 | 0.00% | −18,305−100.0% | Sold out |
| Raiffeisen Bank International AG | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −16,667−100.0% | Sold out |
| Inceptionr LLC | 0 | $0 | 0.00% | −12,375−100.0% | Sold out |
| Cookson Peirce & Co Inc | 0 | $0 | 0.00% | −11,670−100.0% | Sold out |
| Cynosure Management, LLC | 0 | $0 | 0.00% | −10,841−100.0% | Sold out |
| Franklin Street Advisors Inc | 0 | $0 | 0.00% | −10,703−100.0% | Sold out |
| First Hawaiian Bank | 0 | $0 | 0.00% | −9,970−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −9,611−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −9,309−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −9,286−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −8,100−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −8,011−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −7,877−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −7,496−100.0% | Sold out |
| Regal Investment Advisors LLC | 0 | $0 | 0.00% | −7,243−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −6,829−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −6,525−100.0% | Sold out |
| Park Avenue Securities LLC | 0 | $0 | 0.00% | −6,293−100.0% | Sold out |
| Savant Capital, LLC | 0 | $0 | 0.00% | −6,222−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −5,797−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −5,206−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −5,079−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −5,027−100.0% | Sold out |
| CWM Advisors, LLC | 0 | $0 | 0.00% | −4,915−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −4,900−100.0% | Sold out |
| Envestnet Portfolio Solutions, Inc. | 0 | $0 | 0.00% | −4,896−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −4,784−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −4,539−100.0% | Sold out |